JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Literature - Publication Review
The future of immunotherapy gets brighter with base editing
Discover how base editing technology is helping to address the shortcomings of other gene editing technologies for immunotherapy in this literature review.
In this literature review, you will learn about…
- An overview and comparison of autologous and allogeneic CAR-T therapies
- Safety concerns relating to gene editing
- How base editing alleviates safety concerns of other gene editing technologies for immunotherapy
The Pin-point platform technology is available for clinical study and commercialization under a commercial license from Revvity. Pin-point reagents are available for research use only.
To view the full content please answer a few questions
Download Resource
The future of immunotherapy gets brighter with base editing